Data / Form D filings / Navrogen Inc.
Navrogen Inc.: Form D filings
Navrogen Inc., a biotechnology company in Cheyney, PA, filed 6 Form D notices with the SEC between 2018 and 2024. The latest, on June 28, 2024, reports $542,000 sold of a $1 million offering to 13 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1837 UNIVERSITY CIR., SCIENCE CENTER ROOM 218, Cheyney, PA, 19319
- Phone
- (610) 660-1931
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1756608
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 28, 2024 | Amendment | $1,000,000 | $542,000 | $458,000 | 13 | Jun 5, 2024 | sec.gov |
| Jun 27, 2024 | New notice | $1,000,000 | $542,000 | $458,000 | 13 | Jun 5, 2024 | sec.gov |
| Feb 27, 2023 | Amendment | $9,258,328 | $9,059,161 | $199,167 | 20 | Jul 29, 2021 | sec.gov |
| Aug 12, 2021 | New notice | $7,956,662 | $6,955,274 | $1,001,388 | 20 | Jul 29, 2021 | sec.gov |
| Sep 23, 2019 | Amendment | $3,200,000 | $3,200,000 | 18 | Oct 10, 2018 | sec.gov | |
| Oct 23, 2018 | New notice | $2,500,000 | $1,325,000 | $1,175,000 | 9 | Oct 10, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Allan O Bedwick | Director | |
| Luigi C. Grasso | Executive Officer, Director | |
| Nicholas C. Nicolaides | Executive Officer, Director | |
| Leon O Moulder, Jr | Director |
Other biotechnology companies in Pennsylvania that filed recently
- BioLattice Ophthalmics, Inc, $1.8 million · Oct 28, 2026
- Myris Therapeutics, Inc. $500,000 · Oct 14, 2026
- Praeventix, Inc. $5.6 million · Sep 10, 2026
- Plowshare Therapies LLC $6.7 million · Aug 31, 2026
- Noveome Biotherapeutics, Inc. $6.8 million · Aug 27, 2026
- AlloTRx Bio Inc. $500,000 · Aug 24, 2026
Every Form D from the week of Jun 24, 2024 · All recent filings in Pennsylvania · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Navrogen Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.